Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in: Journal of Neurology 9/2017

01-09-2017 | Original Communication

The impact of anger in adherence to treatment and beliefs about disease 1 year after stroke

Authors: A. Catarina Santos, José M. Ferro

Published in: Journal of Neurology | Issue 9/2017

Login to get access

Abstract

Anger is a frequent neuropsychiatric symptom after stroke, which can disrupt treatment and recovery, in particular by affecting adherence behaviour to treatment and health care education. This study aimed to follow-up a cohort of stroke patients 12 months after their stroke to describe the presence of anger, compare levels and profile of acute and post-acute anger and analyse its impact on the adherence to treatment and beliefs about stroke. We followed (13.3 months mean follow-up) 91 stroke patients with a standardized protocol, using State-Trait Anger Expression Inventory-2 (STAXI-2) to assess the frequency and profile of anger and its components and one questionnaire to measure adherence to treatment and health education (meaning on the treatment) (Adh-T). We used as explanatory variables socio-demographic, clinical, stroke type and location information collected during the acute phase. Anger-state was detected in 15 (17%) patients, while anger-trait was present in 7 (8%) patients. The best regression model revealed that trait-anger, stroke location (posterior infarcts), and impact of stroke sequels were independent predictive factors for anger (R 2 = 43%). Patients with higher levels of anger expression had lower adherence rates, independently of the adherence dimension. In the chronic phase after stroke anger was related with posterior lesions, the impact of stroke consequences and anger as a personality trait. The detection and monitoring of anger could eventually prevent the negative impact of anger in care, especially in adherence to rehabilitation and secondary prevention.
Literature
1.
2.
Phillips L, Diefenbach M (2015) Stroke and TIA survivors’ cognitive beliefs and affective responses regarding treatment and future stroke risk differentially predict medication adherence and categorised stroke risk. Psychol Health 30:218–232CrossRefPubMed
3.
O’Carroll R, Whittaker J, Hamilton B (2011) Predictors of adherence to secondary preventive medication in stroke patients. Ann Behav Med 41:383–390CrossRefPubMed
4.
Haynes R, Taylor D, Sackett D (1979) Compliance in health care. Johns Hopkins University Press, Baltimore
5.
Meichenbaum D, Turk D (1987) Treatment adherence: terminology, incidence and conceptualization. In: Meichenbaum D, Turk D (eds) Facilitating treatment adherence. Plenum Press, New York, pp 19–39
6.
Luger S, Hohmann C, Niemann D, Kraft P (2015) Adherence to oral anticoagulant therapy in secondary stroke prevention—impact of the novel oral anticoagulants. Patient Prefer Adherence 9:1695PubMedPubMedCentral
7.
Sauer R, Sauer E, Bobinger T (2015) Adherence to oral anticoagulation in secondary stroke prevention—the first year of direct oral anticoagulants. J Stroke Cerebrovasc Dis 24:78–82CrossRefPubMed
8.
Hohmann C, Neumann-Haefelin T (2013) Adherence to hospital discharge medication in patients with ischemic stroke. Stroke 44:522–524CrossRefPubMed
9.
Gupta A, Deepika S, Taly AB et al (2008) Quality of life and psychological problems in patients undergoing neurological rehabilitation. Ann Indian Acad Neurol 11:225–230CrossRefPubMedPubMedCentral
10.
Meroni R, Beghi E, Beghi M, Brambilla G (2013) Psychiatric disorders in patients suffering from an acute cerebrovascular accident or traumatic injury, and their effects on rehabilitation: an observational study. Eur J Phys Rehabil Med 49:31–39PubMed
11.
12.
Martin R, Watson D, Wan C (2000) A three factor model of trait anger: dimensions of affect, behavior, and cognition. J Pers 68:869–897CrossRefPubMed
13.
14.
Santos CO, Caeiro L, Ferro JM et al (2006) Anger, hostility and aggression in the first days of acute stroke. Eur J Neurol 13:351–358CrossRefPubMed
15.
Ramos-Perdigués S, Mané-Santacana A, Pintor-Pérez L (2015) Revisión sistemática de la prevalencia y factores asociados a la ira tras un ictus. Rev Neurol 60:481–489PubMed
16.
Kim JS, Choi-Kwon S, Kwon SU et al (2005) Fluoxetine improves the post-stroke quality of life in patients with emotional disturbances: a double-blind placebo-controlled study. J Neurol Sci 238 (suppl):S70
17.
Angelelli P, Paolucci S, Bivona U (2004) Development of neuropsychiatric symptoms in poststroke patients: a cross-sectional study. Acta Psychiatr Scand 110:55–63CrossRefPubMed
18.
19.
Redfern J, McKevitt C, Dundas R et al (2000) Behavioral risk factor prevalence and lifestyle change after stroke a prospective study. Stroke 31:1877–1881CrossRefPubMed
20.
21.
22.
Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJWM (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870CrossRefPubMed
23.
Jennett B, Teasdale G (1977) Aspects of coma after severe head injury. Lancet 23:878–881CrossRef
24.
Tatemichi T, Foulkes M, Mohr J, Hewitt J (1990) Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21:858–866CrossRefPubMed
25.
Bamford J, Sandercock P, Dennis M et al (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521–1526CrossRefPubMed
26.
Folstein M, Folstein S, McHugh P (1975) “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
27.
Guerreiro MS, Botelho MA, Leitão O, Castro-Caldas A, Garcia C (1994) Adaptação à população portuguesa da tradução do Mini Mental State Examination (MMSE). Rev Port Neurol 1:9–10
28.
Morgado J, Rocha C, Maruta C (2009) Novos valores normativos do mini-mental state examination. Sinapse 9:10–16
29.
Zigmond A, Snaith R (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
30.
31.
Rankin J (1957) Cerebrovascular accidents in particular in patients over the age of 60. Scott Med J 2:200–215CrossRefPubMed
32.
Bamford J, Sandercock P, Warlow C, Slattery J (1989) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 20:828CrossRefPubMed
33.
Spielberger C (1999) Staxi-2: state-trait anger expression inventory-2; professional manual. Psychological Assessment Resources Inc, Lutz
34.
Marques M, Mendes A, De Sousa L (2007) Adaptação para português do inventário da expressão da ira estado-traço (STAXI-2) de Spielberger. Psychologica 46:85–104
35.
36.
Pamplona A (1997) Estudo da adesão ao tratamento com pacientes de 12 especialidades médicas em regime ambulatório. Universidade de Lisboa, Lisboa
37.
38.
Herrmann MJ, Huter T, Plichta MM et al (2008) Enhancement of activity of the primary visual cortex during processing of emotional stimuli as measured with event-related functional near-infrared spectroscopy and event-related potentials. Hum Brain Mapp 29:28–35. doi:10.​1002/​hbm.​20368 CrossRefPubMed
39.
40.
41.
42.
43.
44.
Toscano M, Viganò A, Puledda F, Verzina A, Rocco A, Lenzi GL, Di Piero V (2014) Serotonergic correlation with anger and aggressive behavior in acute stroke patients: an intensity dependence of auditory evoked potentials (IDAP) study. Eur Neurol 72:186–192CrossRefPubMed
45.
46.
Sharma A, Prasad K, Padma MV (2015) Prevalence of triggering factors in acute stroke: Hospital-based observational cross-sectional study. J Stroke Cerebrovasc Dis 24:337–347CrossRefPubMed
47.
48.
49.
Williams J, Nieto F, Sanford C et al (2002) The association between trait anger and incident stroke risk the atherosclerosis risk in communities (ARIC) study. Stroke 33:13–20CrossRefPubMed
50.
51.
52.
53.
Greenop KR, Almeida OP, Hankey GJ et al (2009) Premorbid personality traits are associated with post-stroke behavioral and psychological symptoms: a three-month follow-up study in Perth, Western Australia. Int Psychogeriatr 21:1063–1071. doi:10.​1017/​S104161020999045​7 CrossRefPubMed
54.
Rush BK, McNeil RB, Gamble DM, Luke SH, Richie AN, Albers CS, Brown RD, Brott TG, Meschia JF (2010) Behavioral symptoms in long-term survivors of ischemic stroke. J Stroke Cerebrovasc Dis 19(4):326–332CrossRefPubMed
55.
Mok VCT, Wong A, Wong K et al (2010) Executive dysfunction and left frontal white matter hyperintensities are correlated with neuropsychiatric symptoms in stroke patients with confluent white matter hyperintensities. Dement Geriatr Cogn Disord 30:254–260. doi:10.​1159/​000318744 CrossRefPubMed
56.
Buijck B, Zuidema S, Eijk M (2012) Neuropsychiatric symptoms in geriatric patients admitted to skilled nursing facilities in nursing homes for rehabilitation after stroke: a longitudinal multicenter study. Int J Geriatr Psychiatry 27:734–741CrossRefPubMed
57.
van Almenkerk S, Depla M, Smalbrugge M (2012) Institutionalized stroke patients: status of functioning of an under researched population. J Am Med Direct Assoc 13:634–639CrossRef
Metadata
Title
The impact of anger in adherence to treatment and beliefs about disease 1 year after stroke
Authors
A. Catarina Santos
José M. Ferro
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 9/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8577-x

Other articles of this Issue 9/2017

Journal of Neurology 9/2017 Go to the issue

Erratum

Erratum to: Lambert–Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer

Original Communication

High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients

Pioneers in Neurology

Michael Kremer (1907–1988)

Review

Lambert–Eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer

Letter to the Editors

Exome sequencing reveals a novel homozygous mutation in ACP33 gene in the first Italian family with SPG21

Original Communication

Post-stroke seizures are clinically underestimated